| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/13/2003 | US20030032618 Pharmaceutical combinations |
| 02/13/2003 | US20030032601 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 02/13/2003 | US20030032593 Transporters comprising spaced arginine moieties |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030031753 Feeding a pet food composition comprising a source of n-6 and n-3 fatty acids, preferably eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); antiinflammatory agents; prostaglandin inhibitors |
| 02/13/2003 | US20030031739 Dietary supplement of an aqueous extract of red vine leaves and carrier; relief of mild-to-moderate leg discomfort; flavonoids; antiinflammatory, -oxidant, -coagulant and -edema properties; hyaluronidase inhibitors |
| 02/13/2003 | US20030031738 Saponin mixtures and compounds are isolated from the species Acacia victoriae; e.g., glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents |
| 02/13/2003 | US20030031733 Pharmaceutical composition for increasing the production of nitric oxide and IFN-gamma, and process for preparation thereof |
| 02/13/2003 | US20030031712 Opioid agonist /antagonist combinations |
| 02/13/2003 | US20030031704 Liposome composition for delivery of nucleic acid |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | US20030031649 Gene therapy to promote angiogenesis |
| 02/13/2003 | US20030031627 For diagnosis and therapy |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | CA2456003A1 Regulator of calcineurin |
| 02/13/2003 | CA2455969A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 02/13/2003 | CA2455963A1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455753A1 Novel 2,4-diaminothiazole derivatives |
| 02/13/2003 | CA2455728A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455711A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455647A1 Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 02/13/2003 | CA2455547A1 Use of vitamin e succinate and antiandrogen combination |
| 02/13/2003 | CA2455520A1 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 02/13/2003 | CA2455358A1 Invert emulsion containing dhea |
| 02/13/2003 | CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454935A1 Method for the nitration of phenolic compounds |
| 02/13/2003 | CA2454147A1 Inhibitor of dna methylation |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452743A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283210A1 Process for preparation of sulfonamide derivatives and crystals thereof |
| 02/12/2003 | EP1283203A1 Crystalline form of 4-(5-methyl-3-phenylisoxazol-4-yl) benzene-sulfonamide |
| 02/12/2003 | EP1283058A1 Agents for preventing or ameliorating insulin resistance and/or obesity |
| 02/12/2003 | EP1283056A1 Medicinal compositions promoting bowel movement |
| 02/12/2003 | EP1283055A1 Soluble beta amyloid precursor protein secretion promoters |
| 02/12/2003 | EP1283053A1 Inhibitors of HER3 activity |
| 02/12/2003 | EP1283050A2 Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| 02/12/2003 | EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody |
| 02/12/2003 | EP1283041A1 Pharmaceutical compositions containing HIV-protease inhibitors |
| 02/12/2003 | EP1283039A1 -secretase inhibitors |
| 02/12/2003 | EP1283037A1 Remedies |
| 02/12/2003 | EP1283036A1 Dry powder for inhalation |
| 02/12/2003 | EP1283035A2 Therapeutic preparation for inhalation containing parathyroid hormone |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282689A1 Specific inhibitors of ribosome recycling factor (rrf) |
| 02/12/2003 | EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 02/12/2003 | EP1282638A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282624A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282623A1 Pyrazolo-triazine derivatives as ligands for gaba receptors |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282620A1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282612A2 Alkynyl phenyl heteroaromatic glucokinase activators |
| 02/12/2003 | EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/12/2003 | EP1282607A2 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282599A1 Disulfide derivatives useful for treating allergic diseases |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 02/12/2003 | EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 02/12/2003 | EP1282440A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents |
| 02/12/2003 | EP1282439A1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |
| 02/12/2003 | EP1282436A2 Treatment of acute coronary syndrome with glp-1 |
| 02/12/2003 | EP1282427A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 02/12/2003 | EP1282425A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 02/12/2003 | EP1282421A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282418A2 Use of pyrazole derivatives for treating infertility |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |